Skip to main content

Advertisement

SpringerLink
Log in

Intravenous treatment of chronic daily headaches in the outpatient headache clinic

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The most likely future of aggressive headache treatment will reside in the sphere of the specialist’s clinic. This is a far more cost- and time-effective mode of treating intractable chronic daily headaches (CDH), including chronic migraines. We have used this technique successfully in our clinic for many years. Our experience with intravenous treatment of headaches and migraines was summarized recently and a 97.5% success rate for this type of treatment was found in the clinic. Compared with the treatments commonly available in the emergency department, the specialist’s clinic can offer more effective headache-altering definitive treatments. Patients can be offered a maximum degree of success for control of their intractable headaches. In this article, approaches to aggressive treatment of ongoing CDH using intravenous methods of therapy are discussed. All of these can be performed in the clinic setting, avoiding some of the costly aspects of treatment that are present in an emergency room setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Krusz JC, Scott-Krusz V, Cagle J, Belanger J: Outpatient clinic treatment of headache and migraine fiare-ups. Poster abstract presented at: EFNS. Athens, Greece: September 2005.

  2. Krusz JC, Belanger J: Cost effectiveness of clinic treatment of headaches and pain. Oral platform presented at 8th World Congress. Tenerife, Canary Islands: The Pain Clinic, 1998.

    Google Scholar 

  3. Richter PA, Burk MP: The potentiation of narcotic analgesics with phenothiazines. J Foot Surg 1992, 31:378–380.

    PubMed  CAS  Google Scholar 

  4. Vinson DR: Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med 2002, 39:215–222.

    Article  PubMed  Google Scholar 

  5. Friedman BW, Corbo J, Lipton RB, et al.: A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005, 64:463–468.

    PubMed  CAS  Google Scholar 

  6. Taylor BK, Joshi C, Uppal H: Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits infiammatory pain. Brain Res 2003, 987:135–143.

    Article  PubMed  CAS  Google Scholar 

  7. Flores JA, El Banoua F, Galan-Rodriguez B, Fernandez-Espejo E: Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 2004, 110:205–214.

    Article  PubMed  CAS  Google Scholar 

  8. King MA, Bradshaw S, Chang AH, et al.: Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active antiopioid system. J Neurosci 2001, 21:7788–7792.

    PubMed  CAS  Google Scholar 

  9. Semenchuk MR, Davis B: Efficacy of sustained-release bupropion in neuropathic pain: an open-label study. Clin J Pain 2000, 16:6–11.

    Article  PubMed  CAS  Google Scholar 

  10. Wang SJ, Silberstein SD, Young WB: Droperidol treatment of status migrainosus and refractory migraine. Headache 1997, 37:377–382.

    Article  PubMed  CAS  Google Scholar 

  11. Krusz JC, Scott VB, Belanger J IV: Droperidol as a treatment for acute migraine headache. Poster presented at the International Headache Society World Congress. Barcelona: June 1999. Cephalalgia 1999, 19:356.

  12. Silberstein SD, Young WB, Mendizabal JE, et al.: Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology 2003, 60:315–321.

    PubMed  CAS  Google Scholar 

  13. Jones J, Pack S, Chun E: Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med 1996, 14:262–264.

    Article  PubMed  CAS  Google Scholar 

  14. Ginder S, Oatman B, Pollack M: A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. J Emerg Med 2000, 18:311–315.

    Article  PubMed  CAS  Google Scholar 

  15. Mauskop A, Altura BT, Cracco RQ, Altura BM: Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996, 36:154–160.

    Article  PubMed  CAS  Google Scholar 

  16. Krusz JC, Belanger J: Intravenous magnesium sulfate in the treatment of headaches. Poster presented at the American Academy of Pain Management Annual Meeting. Atlanta: September 1998.

  17. Mauskop A, Altura BM: Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 1998, 5:24–27.

    PubMed  CAS  Google Scholar 

  18. Mauskop A, Altura BT, Cracco RQ, Altura BM: Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache 1995, 35:597–600.Pioneering article describing aberrations in magnesium content and potential treatment using IV MgSO4 infusion for the treatment of cluster headache.

    Article  PubMed  CAS  Google Scholar 

  19. Unger J, Cady RK, Farmer-Cady K: Understanding migraine: treatment options. Emerg Med 2003, 9:50–55.Well-written article describing useful approaches to migraine treatments.

    Google Scholar 

  20. Raskin NH: Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986, 36:995–997.

    PubMed  CAS  Google Scholar 

  21. Scherl ER, Wilson JF: Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 1995, 35:256–259.

    Article  PubMed  CAS  Google Scholar 

  22. Klapper J: The pharmacologic treatment of acute migraine headaches. J Pain Symptom Manage 1993, 8:140–147.

    Article  PubMed  CAS  Google Scholar 

  23. Klapper JA, Stanton JS: Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache 1991, 31:523–524.

    Article  PubMed  CAS  Google Scholar 

  24. Rozen TD: Migraine headache: immunosuppressant therapy. Curr Treat Options Neurol 2002, 4:395–401.

    PubMed  Google Scholar 

  25. Saadah HA: Abortive migraine therapy in the office with dexamethasone and prochlorperazine. Headache 1994, 34:366–370.

    Article  PubMed  CAS  Google Scholar 

  26. Gallagher RM: Emergency treatment of intractable migraine. Headache 1986, 28:74–75.

    Article  Google Scholar 

  27. Hering R, Kuritsky A: Sodium valproate has a prophylaxis effect in migraine: a double-blind study vs placebo. Cephalalgia 1992, 12:81–48.

    Article  PubMed  CAS  Google Scholar 

  28. Jensen R, Brinck T, Olesen J: Sodium valproate has a prophylactic effect in migraine without aura. Neurology 1994, 44:647–651.

    PubMed  CAS  Google Scholar 

  29. Klapper JA: Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997, 17:103–108.

    Article  PubMed  CAS  Google Scholar 

  30. Krusz JC, Scott VB, Belanger J: Intravenous valproate sodium in the treatment of refractory migraine headaches. Poster presented at the Headache Update Annual Meeting. Orlando: July 1999.

  31. Mathew NT, Kailasam J, Meadors L, et al.: Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 2000, 40:720–723.

    Article  PubMed  CAS  Google Scholar 

  32. Edwards KR, Norton J, Behnke M: Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001, 41:976–980.

    Article  PubMed  CAS  Google Scholar 

  33. Krusz JC: Intravenous valproate sodium in the treatment of migraine headaches in the headache clinic. Headache Quarterly 2003, 12:39–41.

    Google Scholar 

  34. Schwartz TH, Karpitskiy VV, Sohn RS: Intravenous valproate sodium in the treatment of daily headache. Headache 2002, 42:519–522.

    Article  PubMed  Google Scholar 

  35. Tanen DA, Miller S, French T, Riffenburgh RH: Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg Med 2003, 41:847–853.

    Article  PubMed  Google Scholar 

  36. Stillman MJ, Zajac D, Rybicki LA: Treatment of primary headache disorders with intravenous valproate: initial outpatient experience. Headache 2004, 44:65–69.

    Article  PubMed  Google Scholar 

  37. Krusz JC, Scott V, Belanger J: Intravenous propofol: unique effectiveness in treating intractable migraine headaches. Headache 2000, 40:41–46.

    Article  Google Scholar 

  38. Krusz JC: Prophylaxis for chronic daily headache and chronic migraine with neuronal stabilizing agents. Curr Pain Headache Rep 2002, 6:480–485.

    PubMed  Google Scholar 

  39. Bell R, Montoya D, Shuaib A, Lee MA: A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990, 19:1079–1082.

    Article  PubMed  CAS  Google Scholar 

  40. Reutens DC, Fatovich DM, Stewart-Wynne EG, Prentice DA: Is intravenous lidocaine clinically effective in acute migraine? Cephalalgia 1991, 11:245–247.

    Article  PubMed  CAS  Google Scholar 

  41. Hand PJ, Stark RJ: Intravenous lignocaine infusions for severe chronic daily headache. Med J Aust 2000, 172:157–159.

    PubMed  CAS  Google Scholar 

  42. Williams DR, Stark RJ: Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003, 23:963–971.

    Article  PubMed  CAS  Google Scholar 

  43. Krusz JC, Longmire DR: Tramadol in the treatment of headaches [Abstract]. Poster presented at the American Academy of Pain Management Annual Meeting. Washington, DC: September 1996.

  44. Krusz JC, Daniel D, Cagle J: IV tramadol for treatingrefractory migraines [Abstract]. Poster presented at the 7th Congress European Federation of Neurological Societies. Helsinki, Finland: August 2003. Eur J Neurol 2003, 10(suppl 1):74–75.

    Google Scholar 

  45. Krusz JC: Levetiracetam (Keppra TM) as prophylaxis for resistant headaches [Abstract]. Poster presented at the Headache Update 2000. Lake Buena Vista, FL. Headache Quarterly 2000, 12:54.

    Google Scholar 

  46. Krusz JC, Cagle J, Daniel D: Intravenous levetiracetam for acute intractable migraines. Poster presented at the 14th Migraine Trust International Symposium. London: September 2002. Cephalalgia 2002, 22:604.

    Google Scholar 

  47. Krusz JC, Daniel D, Cagle J: IV Levetiracetam efficacious for cluster headache. Poster presented at the XI Congress of the International Headache Society. Rome: September 2003. Cephalalgia 2003, 23:736.

    Google Scholar 

  48. Nicolodi M, Sicuteri F: Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int J Clin Pharmacol Res 1995, 15:181–189.

    PubMed  CAS  Google Scholar 

  49. Nicolodi M, Sicuteri F: Negative modulators of excitatory amino acids in episodic and chronic migraine: preventing and reverting chronic migraine. Special lecture at the 7th INWIN Congress. Int J Clin Pharmacol Res 1998, 18:93–100.

    PubMed  CAS  Google Scholar 

  50. Kaube H, Herzog J, Kaufer T, et al.: Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 2000, 55:139–141.

    Article  PubMed  CAS  Google Scholar 

  51. Peres MF, Zukerman E, Soares C, et al.: CSF glutamate levels in chronic migraine [Abstract]. Cephalalgia 2004, 24:151–152.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anodyne Headache and PainCare, 5446 Glen Lakes Drive, 75231, Dallas, X, USA

    John Claude Krusz PhD, MD

Authors
  1. John Claude Krusz PhD, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Claude Krusz PhD, MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krusz, J.C. Intravenous treatment of chronic daily headaches in the outpatient headache clinic. Current Science Inc 10, 47–53 (2006). https://doi.org/10.1007/s11916-006-0009-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-006-0009-z

Keywords

Search

Navigation